CMS Clarifies Medicare Policy For Embolic Protection With Carotid Stenting
This article was originally published in The Gray Sheet
Executive Summary
CMS revised its carotid artery stenting policy Dec. 9 to ensure that new embolic protection devices used in conjunction with carotid stents are covered by Medicare, and to clarify that the stenting procedure cannot be covered without the use of a protection device
You may also be interested in...
Carotid Stenting: CREST Makes A Splash, But Market Will Depend On CMS
Carotid stent makers and interventionalists plan to use recently reported CREST trial data to argue for expanded Medicare coverage that allows more patients to receive the devices, but potential obstacles remain
Carotid Stenting: CREST Makes A Splash, But Market Will Depend On CMS
Carotid stent makers and interventionalists plan to use recently reported CREST trial data to argue for expanded Medicare coverage that allows more patients to receive the devices, but potential obstacles remain
New Data Gives Carotid Stenting A Third Shot At Broader Medicare Coverage
CMS is again considering whether to expand Medicare coverage for carotid artery stenting